Showing results (111-120 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|March 14, 2023
Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapseFrances K Turrell, Rebecca Orha, Naomi J Guppy, et al.Nature Cancer|March 17, 2023
Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironmentSayali Onkar, Jian Cui, Jian Zou, et al.Nature Cancer|August 18, 2022
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcomaYun Wei, Qian Qin, Chuan Yan, et al.Nature Cancer|August 20, 2021
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1Rodrigo Romero, Francisco J Sánchez-Rivera, Peter M K Westcott, et al.Nature Cancer|November 10, 2022
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunityLei Tian, Bo Xu, Yuqing Chen, et al.Nature Cancer|January 8, 2026
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemiaKadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.Nature Cancer|January 8, 2026
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunityPilar M Moreno-Sanchez, Mahsa Rezaeipour, Else Marit Inderberg, et al.Nature Cancer|November 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signaturesElinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, et al.Nature Cancer|January 16, 2026
Glucagon-like peptide-1 medicines and cancerJulian M Yabut, Daniel J DruckerNature Cancer|May 16, 2025
MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonizationSeverin Guetter, Courtney König, Huiqin Koerkel-Qu, et al.Pageof 65